False-positive iodine-131 whole-body scans due to cholecystitis and sebaceous cyst

Journal of Nuclear Medicine

Volumn 37, Issue 10, 1996, Pages 1690-1693

  Brucker Davis, Françoise ^a   Reynolds, James C ^b   Skarulis, Monica C ^b   Fraker, Douglas L ^b   Alexander, H Richard ^b   Weintraub, Bruce D ^b   Robbins, Jacob ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NONE

Author keywords

cholecystitis; iodine 131; sebaceous cyst; thyroid cancer; whole body scan

Indexed keywords

IODINE 131;

ADULT; ARTICLE; CANCER DIAGNOSIS; CASE REPORT; CHOLECYSTITIS; COLLIMATOR; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IMAGE QUALITY; MALE; METASTASIS; PRIORITY JOURNAL; SEBACEOUS CYST; THYROGLOBULIN BLOOD LEVEL; THYROID CANCER; WHOLE BODY SCINTISCANNING;

ADENOCARCINOMA, FOLLICULAR; CARCINOMA, PAPILLARY; CHOLECYSTITIS; EPIDERMAL CYST; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 0029819041     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Maxon HR III, Smith HS. Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. Endocrinol Metab Clin North Am 1990;19:685-718.
2. Fogelman I, Maisey MN. The thyroid scan in the management of thyroid disease. In: Freedman LM, Weissmann HS, eds. Nuclear medicine annual. New York: Raven Press; 1989:1.
3. Ozata M, Suzuki S, Miyamoto T, Liu RT, Fierro-Renoy F, DeGroot LJ. Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer. J Clin Endocrinol Metab 1994;79:98-105.
4. 131I scans in post-therapy patients with differentiated carcinoma: concise communication. J Nucl Med 1982;23:235-240.
5. Balachandran S, Sayle BA. Value of thyroid carcinoma imaging after therapeutic doses of radioiodine. Clin Nucl Med 1981;6:162-167.
6. Meier CA, Braverman LE, Ebner SA, et al. Diagnostic use of recombinant thyrotropin in patients with thyroid carcinoma (phase I/II study). J Clin Endocrinol Metab 1994;78:188-196.
7. Pineda JD, Lee T, Ain K, Reynolds J, Robbins J. Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative scan. J Clin Endocrinol Metab 1995;80:1488-1492.
8. Fink-Bennett D, Balon H, Robbins T, Tsai D. Morphine-augmented cholescintigraphy: its efficacy in detecting acute cholecystitis. J Nucl Med 1991;32:1231-1233.
9. Greenler DP, Klein HA. The scope of false-positive iodine-131 images for thyroid carcinoma. Clin Nucl Med 1989;14:111-117.
10. Bakheet SM, Hammami MM. False-positive radioiodine whole-body scan in thyroid cancer patients due to unrelated pathology. Clin Nucl Med 1994;19:325-329.
11. 131I total-body scans. J Nucl Med 1974;15:1052-1053.
12. Abdel-Dayem HM, Halker K, El Sayed M. The radioactive wig in iodine-131 whole-body imaging. Clin Nucl Med 1985;9:454-455.
13. 131I uptake at a tracheostomy site. Discernment with T1-201 imaging. Clin Nucl Med 1994;19:619-621.
14. Ceccarelli C, Pacini F, Lippi F, Pinchera A. An unusual case of a false-positive whole-body scan in a patient with papillary thyroid cancer. Clin Nucl Med 1988;13: 192-193.
15. 131I of tracheostomy site on a total-body scan. Clin Nucl Med 1984;9:409-411.
16. Park HM, Tarver RD, Schauwecker DS, Burt R. Spurious thyroid cancer metastasis: saliva contamination artifact in high dose iodine-131 metastases survey. J Nucl Med 1986;27:634-636.
17. Bakheet S, Hammami MM. False-positive thyroid cancer metastasis on whole-body radioiodine scanning due to retained radioactivity in the esophagus. Eur J Nucl Med 1993;20:415-419.
18. 131I in a hiatal hernia mimicking recurrence of papillary thyroid carcinoma. Clin Nucl Med 1993;18:961-963.
19. 131I scan induced by Zenker's diverticulum. Clin Nucl Med 1992;17:243-244.
20. Kistler AM, Yudt WM, Bakalar RS, Turton DB, Silverman ED. Retained esophageal activity on iodine-131 survey in patient with benign esophageal stricture. Clin Nucl Med 1993;18:908-909.
21. Caplan RH, Gundersen GA, Abellara RM, Kisken WA. Uptake of iodine-131 by a Meckel's diverticulum mimicking metastatic thyroid cancer. Clin Nucl Med 1987;12: 760-762.
22. Achong DM, Oates E, Lee SL, Doherty FJ. Gallbladder visualization during post-therapy iodine-131 imaging of thyroid carcinoma. J Nucl Med 1991;32:2275-2277.
23. Geatti O, Shapiro B, Orsolon PG, Mirolo R, Di Donna A. An unusual false-positive scan in a patient with pericardial effusion. Clin Nucl Med 1994;19:678-682.
24. Hoschl R, Choy DHL, Gandevia B. Iodine-131 uptake in inflammatory lung disease: a potential pitfall in treatment of thyroid carcinoma. J Nucl Med 1988;29:701-703.
25. Maslack MM, Wilson CA. Iodine-131 accumulation in a pericardial effusion. J Nucl Med 1987;28:133.
26. Brachman MB, Rothman BJ, Ramanna L, Tanasescu DE, Adelberg H, Waxman AD. False-positive iodine-131 whole-body scan caused by a large renal cyst. Clin Nucl Med 1988;13:416-418.
27. Acosta J, Chitkara R, Khan F, Azueta V, Silver L. Radioactive iodine uptake by a large-cell undifferentiated bronchogenic carcinoma. Clin Nucl Med 1982;7:368-369.
28. Bakheet S, Hammami MM. Spurious lung metastases on radioiodine thyroid and whole-body imaging. Clin Nucl Med 1993;18:307-312.
29. 131I scan. JAMA 1976;236:857-859.
30. 131I uptake in a benign serous cystadenoma of the ovary. Eur J Nucl Med 1984;9:433-435.
31. Langsteger W, Koltringer P, Wolf G, Eber B, Semlitsch G, Eber O. False-positive radioiodine uptake in lung carcinoma. J Nucl Med 1994;35:2056-2057.
32. Lakshmanan M, Reynolds JC, Del Vecchio S, Merino MJ, Norton JA, Robbins J. Pelvic radioiodine uptake in a rectal wall teratoma after thyroidectomy for papillary carcinoma. J Nucl Med 1992;33:1848-1850.
33. 131I by a papillary meningioma. Am J Roetgenol 1977;129:349-350.
34. 131I by an abdominal neurilemoma mimicking metastatic thyroid carcinoma. Clin Nucl Med 1993;18:964-966.
35. Wu SY, Kollin J, Coodley E, et al. Iodine-131 total-body scan: localization of disseminated gastric adenocarcinoma. Case report and survey of the literature. J Nucl Med 1984;25:1204-1209.
36. Yeh EL, Meade RC, Ruetz PP. Radionuclide study of struma ovarii. J Nucl Med 1973;14:118-121.
37. Zwas ST, Heyman Z, Lieberman LM. Iodine-131 ovarian uptake in a whole-body scan for thyroid carcinoma. Semin Nucl Med 1989;19:340-342.
38. 123I in a Warthin's tumor. Clin Nucl Med 1978;3:155-156.
39. 131I total-body scan due to an ectasia of the common carotidis. J Endocrinol Invest 1993;16:207-211.
40. Jackson GL, Graham WP, Flickinger FW, et al. Thymus accumulation of radioactive iodine. Pennsylvania Med 1979;82:37.
41. Muherji S, Ziessman HA, Earll JM, et al. False-positive iodine-131 whole-body scan due to pectus excavatum. Clin Nucl Med 1988;13:207-208.
42. Klebanoff SJ, Hamon CB. Role of myeloperoxidase-mediated antimicrobial systems in intact leukocytes. J Reticuloendothel Soc 1972;12:170-196.
43. Klebanoff SJ. Iodination of bacteria: a bactericidal mechanism. J Exper Med 1967;126:1063-1078.
44. 131I-labeled iodide, thyroxine and triiodothyronine, and its relation to thyroid function. J Clin Endocrinol Metab 1964;24:313-318.
45. Van Den Broek PJ, Buys LFM, Van Furth R. Interaction of Povidone-iodine compounds, phagocytic cells and microorganisms. Antimicrob Agents Chemother 1982;22:593-597.
46. 131I scan dose in patients with thyroid cancer: determination of ablation (concise communication). J Nucl Med 1981;22:861-865.